1. Home
  2. VNDA vs IBEX Comparison

VNDA vs IBEX Comparison

Compare VNDA & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • IBEX
  • Stock Information
  • Founded
  • VNDA 2002
  • IBEX 2017
  • Country
  • VNDA United States
  • IBEX United States
  • Employees
  • VNDA N/A
  • IBEX N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • IBEX EDP Services
  • Sector
  • VNDA Health Care
  • IBEX Technology
  • Exchange
  • VNDA Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • VNDA 282.8M
  • IBEX 267.7M
  • IPO Year
  • VNDA 2006
  • IBEX 2020
  • Fundamental
  • Price
  • VNDA $4.77
  • IBEX $25.22
  • Analyst Decision
  • VNDA Strong Buy
  • IBEX Buy
  • Analyst Count
  • VNDA 2
  • IBEX 2
  • Target Price
  • VNDA $16.50
  • IBEX $25.00
  • AVG Volume (30 Days)
  • VNDA 652.5K
  • IBEX 247.1K
  • Earning Date
  • VNDA 05-07-2025
  • IBEX 05-08-2025
  • Dividend Yield
  • VNDA N/A
  • IBEX N/A
  • EPS Growth
  • VNDA N/A
  • IBEX 37.48
  • EPS
  • VNDA N/A
  • IBEX 2.13
  • Revenue
  • VNDA $198,772,000.00
  • IBEX $521,725,000.00
  • Revenue This Year
  • VNDA $14.36
  • IBEX $6.47
  • Revenue Next Year
  • VNDA $44.53
  • IBEX $4.29
  • P/E Ratio
  • VNDA N/A
  • IBEX $12.24
  • Revenue Growth
  • VNDA 3.18
  • IBEX 1.66
  • 52 Week Low
  • VNDA $3.71
  • IBEX $13.00
  • 52 Week High
  • VNDA $6.75
  • IBEX $27.83
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 48.67
  • IBEX 53.86
  • Support Level
  • VNDA $4.84
  • IBEX $23.82
  • Resistance Level
  • VNDA $5.04
  • IBEX $26.76
  • Average True Range (ATR)
  • VNDA 0.22
  • IBEX 1.01
  • MACD
  • VNDA -0.01
  • IBEX -0.04
  • Stochastic Oscillator
  • VNDA 26.32
  • IBEX 47.62

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: